153 related articles for article (PubMed ID: 25953804)
1. The combination of ampicillin plus ceftaroline is synergistic against Enterococcus faecalis.
Werth BJ; Abbott AN
J Antimicrob Chemother; 2015 Aug; 70(8):2414-7. PubMed ID: 25953804
[No Abstract] [Full Text] [Related]
2. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
[TBL] [Abstract][Full Text] [Related]
3. Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.
Luther MK; Rice LB; LaPlante KL
Antimicrob Agents Chemother; 2016 May; 60(5):3178-82. PubMed ID: 26926624
[TBL] [Abstract][Full Text] [Related]
4. In vitro synergy of ampicillin with gentamicin, ceftriaxone and ciprofloxacin against Enterococcus faecalis.
Liao CH; Huang YT; Tsai HY; Hsueh PR
Int J Antimicrob Agents; 2014 Jul; 44(1):85-6. PubMed ID: 24888868
[No Abstract] [Full Text] [Related]
5. In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin.
Farina C; Russello G; Chinello P; Pasticci MB; Raglio A; Ravasio V; Rizzi M; Scarparo C; Vailati F; Suter F;
Chemotherapy; 2011; 57(5):426-33. PubMed ID: 22122863
[TBL] [Abstract][Full Text] [Related]
6. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of ampicillin-ceftriaxone against Enterococcus faecalis isolates recovered from invasive infections].
Burguer Moreira N; Nastro M; Vay C; Famiglietti Á; Rodríguez CH
Rev Argent Microbiol; 2016; 48(1):57-61. PubMed ID: 26857425
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F
J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
[TBL] [Abstract][Full Text] [Related]
10. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with ampicillin and daptomycin for treatment of Enterococcus faecalis endocarditis.
Sierra-Hoffman M; Iznaola O; Goodwin M; Mohr J
Antimicrob Agents Chemother; 2012 Nov; 56(11):6064. PubMed ID: 22964255
[No Abstract] [Full Text] [Related]
13. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
Arias CA; Singh KV; Panesso D; Murray BE
Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057
[TBL] [Abstract][Full Text] [Related]
14. Gentamicin-resistant Enterococcus faecalis sequence type 6 with reduced penicillin susceptibility: diagnostic and therapeutic implications.
Guardabassi L; Larsen J; Skov R; Schønheyder HC
J Clin Microbiol; 2010 Oct; 48(10):3820-1. PubMed ID: 20702669
[No Abstract] [Full Text] [Related]
15. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A
Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
[TBL] [Abstract][Full Text] [Related]
16. Breakthrough bacteraemia with a susceptible Enterococcus faecalis during tigecycline monotherapy.
Parsonage M; Shah S; Moss P; Thaker H; Meigh R; Balaji A; Elston J; Barlow G
J Antimicrob Chemother; 2010 Feb; 65(2):370-4. PubMed ID: 20022936
[No Abstract] [Full Text] [Related]
17. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.
Gavaldà J; Len O; Miró JM; Muñoz P; Montejo M; Alarcón A; de la Torre-Cisneros J; Peña C; Martínez-Lacasa X; Sarria C; Bou G; Aguado JM; Navas E; Romeu J; Marco F; Torres C; Tornos P; Planes A; Falcó V; Almirante B; Pahissa A
Ann Intern Med; 2007 Apr; 146(8):574-9. PubMed ID: 17438316
[TBL] [Abstract][Full Text] [Related]
18. Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates.
Metzidie E; Manolis EN; Pournaras S; Sofianou D; Tsakris A
J Antimicrob Chemother; 2006 Jan; 57(1):158-60. PubMed ID: 16308417
[No Abstract] [Full Text] [Related]
19. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.
Gavaldà J; Torres C; Tenorio C; López P; Zaragoza M; Capdevila JA; Almirante B; Ruiz F; Borrell N; Gomis X; Pigrau C; Baquero F; Pahissa A
Antimicrob Agents Chemother; 1999 Mar; 43(3):639-46. PubMed ID: 10049280
[TBL] [Abstract][Full Text] [Related]
20. Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline.
Sakoulas G; Nonejuie P; Nizet V; Pogliano J; Crum-Cianflone N; Haddad F
Antimicrob Agents Chemother; 2013 Aug; 57(8):4042-5. PubMed ID: 23689728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
